Quantcast

Latest Prostate cancer screening Stories

2011-03-28 09:37:00

ATLANTA, March 28, 2011 /PRNewswire/ -- As a culmination of the efforts behind the Prostate Cancer Awareness Pledge Campaign, there will be a prostate cancer symposium on Saturday, April 2, 2011 held at the Morehouse School of Medicine located at 720 Westview Drive SW, Atlanta, GA 30310 from 10 a.m. until 3 p.m. (Logo: http://photos.prnewswire.com/prnh/20101203/CL11764LOGO-b ) Prostate cancer is a serious health concern in Georgia. According to the American Cancer Society, the state of...

2011-01-11 14:33:40

In July 2010, a research team led by Jonas Hugosson, professor in urology at the Sahlgrenska Academy, presented the results of a large randomised study of screening for prostate cancer in Gothenburg, with a 14-year follow up. The results were published in the prestigious journal The Lancet Oncology. The study included 10,000 men (the screening group) aged 50-64 years who were randomly assigned to regular blood samples to check their level of a prostate cancer marker known as PSA (Prostate-...

2010-06-16 08:15:00

WASHINGTON, June 16 /PRNewswire-USNewswire/ -- Widespread budget crises now being addressed by legislatures across the country could have a potentially disastrous effect on State-based health initiatives across America. In Illinois, as a critical example, the legislature is finalizing its budget for FY 2011, and a key program threatened is the state's long-running Prostate and Testicular Cancer Program. This program could be cut in its entirety as early as July this year. Since 2000, the...

2010-05-23 12:00:00

CAMBRIDGE, Mass., May 23 /PRNewswire/ -- Quanterix Corporation, the single molecule diagnostics company focused on developing and commercializing high sensitivity tests, announced the publication of a breakthrough study of the company's proprietary technology that demonstrates an unprecedented sensitivity for measuring a biomarker for prostate cancer recurrence. The research article, featured on the cover of the June issue (Volume 28, No. 6) of Nature Biotechnology, describes how...

2010-03-05 12:59:22

Men who undergo prostate-cancer screening should discuss with a doctor the uncertainties, risks and benefits of the test before it is performed, says Edward Partridge, M.D., president-elect of the American Cancer Society (ACS) National Board of Directors and director of the University of Alabama at Birmingham (UAB) Comprehensive Cancer Center. "We reaffirm the importance of informed and shared decision-making between a man and his doctor regarding prostate screening," Partridge says. "We want...

2010-03-01 10:15:00

Health Care Reform Highlights Need for Better Screening and Prevention Foundation for Improving Prostate Imaging Technology Praises House Committee for Hearing WASHINGTON, March 1 /PRNewswire-USNewswire/ -- AdMeTech Foundation announced today that its President and CEO Dr. Faina Shtern will testify on March 4 before the U.S. House Committee on Oversight and Government Reform on how health care reform highlights the need for increased funding for research aimed at creating accurate,...

2009-11-10 18:36:51

New Mayo Clinic research studied the association between prostate-specific antigen (PSA) levels and prostate size and found that routine annual evaluation of prostate growth is not necessarily a predictor for the development of prostate cancer. However the study suggests that if a man's PSA level is rising quickly, a prostate biopsy is reasonable to determine if he has prostate cancer. These findings are being presented this week at the North Central Section of the American Urological...

2009-11-05 13:39:38

European Urology article discusses results from large study The November issue of European Urology, the official journal of the European Association of Urology, features an article focusing on prostate specific antigen (PSA) velocity and early cancer detection. It has been suggested that changes in PSA over time aid prostate cancer detection. It is argued that a rapidly rising PSA may indicate a greater risk of diagnosis of prostate cancer even if PSA levels are low. Some guidelines do...

2009-11-04 12:51:34

A diagnosis of prostate cancer raises the question for patients and their physicians as to how the tumor will behave. Will it grow quickly and aggressively and require continuous treatment, or slowly, allowing therapy and its risks to be safely delayed? The answer may lie in the size and shape of the blood vessels that are visible within the cancer, according to research led by investigators at The Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard...

2009-09-28 07:17:17

Prostate cancer patients of low socioeconomic status are more likely to die than patients with higher incomes. That is the finding of a new study from Swiss researchers to be published in the December 1, 2009 issue of Cancer, a peer-reviewed journal of the American Cancer Society. The study's findings indicate that poor prostate cancer patients receive worse care than their wealthier counterparts. Many of the previous studies on socioeconomic status (SES) and prostate cancer mortality are...


Word of the Day
bodacious
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'
Related